Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
vgx-3100 (3 trials)
Carcinoma in Situ (Phase 2)
Cervical Intraepithelial Neoplasia (Phase 2)
Neoplasms (Phase 2)
Papillomavirus Infections (Phase 1)
Trials (3 total)
Trial APIs (1 total)